1. Catalogs
  2. WELLS BIO
  3. WELLS BIO MDx Portfolio Brochure_Eng

WELLS BIO MDx Portfolio Brochure_Eng
1 /20Pages

WELLS BIO MDx Portfolio Brochure_Eng

WELLS BIO MDx Portfolio Brochure_Eng
1 /20Pages

Catalog excerpts

WELLS BIO MDx Portfolio Brochure_Eng-1

Portfolio Molecular diagnostic testing detects specific sequences in DNA or RNA through sensitive and specific clinical laboratory techniques, namely polymerase chain reaction (PCR). It enables not only early detection of major infectious diseases, inherited conditions, and molecular oncology, but also allows to have a greater impact on the treatment and care of patients.

 Open the catalog to page 1
WELLS BIO MDx Portfolio Brochure_Eng-2

Magok R&D Center & GMP Production Facility - Venture company certification, company affiliated research institute establishment WELLS BIO, Inc. is researching, developing, and producing products based on immunodiagnosis, biosensor, and molecular diagnosis technology based on in vitro diagnosis technology that diagnoses diseases at an early stage. In this era when the importance of early diagnosis and treatment is on the rise due to the aging of mankind and globalization of diseases, Wells Bio will be with mankind as the world's best in vitro diagnostic company.

 Open the catalog to page 2
WELLS BIO MDx Portfolio Brochure_Eng-3

WELLS BIO has molecular technologies to diagnose infection and genetic disorders utilizing genetic information such as DNA and RNA. These technologies enable us to examine DNA/RNA of target molecules allowing us to obtain more accurate results diagnosis compared to conventional immunological or biochemical diagnostic products. Our molecular diagnostic technologies significantly contribute to obtaining accurate diagnosis of diseases. Additionally, molecular genotyping analysis makes it possible to achieve custom diagnosis that is specific to individual patients. Our multiplexing molecular diagnostic...

 Open the catalog to page 3
WELLS BIO MDx Portfolio Brochure_Eng-4

Q1 Amplifier careSTART™ Q1 Amplifier is based on the excellent quality of the LineGene family, using the very mature thermoelectric refrigeration technology, a new light source and optical circuit design. The unique constant current power supply and 6-zone independent temperature control method ensure that the product is fast, accurate and stable in fluorescence quantitative analysis. The product adopts modular design, with a variety of configuration options, at the same time, the addition of temperature gradient, sample 4°C cryopreservation, automatic dehumidification and other functions, fully...

 Open the catalog to page 4
WELLS BIO MDx Portfolio Brochure_Eng-5

Test summary : The test data of 96 samples shown in the figure above were analyzed according to the baseline threshold method: avgCt=24.40667, std=0.049133, and CV=0.2%, indicating that careSTART™ Q1 Amplifier real-time fluorescence quantitative PCR analyzer had very good repeatability in fluorescence detection wells. Case 2 : Absolute quantification - Fluorescence detection sensitivity test Test summary : Summary: as shown in the figure above, it can be seen from the 1.5 times concentration of HBV fluorescence quantitative detection kit that the measured mean Ct value of 1.5 times concentration...

 Open the catalog to page 5
WELLS BIO MDx Portfolio Brochure_Eng-6

STD-12 detection kit 70 to 80% of Sexually transmitted diseases (STD) are asymptomatic even though they are infected. If not treated properly, women may cause vaginitis, cervical cancer, and urethritis, which can cause serious complications such as abortion, premature birth, and infertility. The STD tests with conventional end point PCR are used but have the complexity of the test and risk of cross-contamination concerns. Therefore, we adopted real-time PCR method, with has already been validated by several products, improves the accuracy and usability of the test. (5^ Features marked | KMFDSapproved...

 Open the catalog to page 6
WELLS BIO MDx Portfolio Brochure_Eng-7

HPV is an etiologic agent for one of the most common sexually transmitted diseases. More than 100 viral types of HPV have been identified. Over 30 types of the HPV are associated with sexually transmitted infections and certain high-risk HPV can cause cancers of the cervix, vagina, vulva, penis and anus. Because 40% of HPV infections are mixed infection, the accurate identification of high-risk HPV genotypes, especially HPV 16 or HPV 18 in mixed infection, is important for assessing the risk of progression to a cervical cancer. • Demonstrates no cross-reactivity, ensuring that positive results...

 Open the catalog to page 7
WELLS BIO MDx Portfolio Brochure_Eng-8

marked | KMFDS approved The careGENE™ HPV detection kit-M is designed to detect 25 types of human papillomavirus types (HPV). In conjunction with qPCR, it can genotype 4 high-risk HPVs (16,18,31, and 59) and 3 low-risk HPVs (6,53, and 61). It can collectively detect 10 other high-risk HPVs (HPV 33,35,39,45, 51,52,56,58,66, and 68), and 8 other low-risk HPVs (HPV 11,40,43,44,54,70, 73, and 81) from crude cervical scraping (Liquid based Cytology). This kit was developed based on TaqMan probe qPCR technology, utilizing polymerase chain reaction (PCR) for the amplification of specific target sequences...

 Open the catalog to page 8
WELLS BIO MDx Portfolio Brochure_Eng-9

careBENy™ pneUm0nj3 (jeteCtiOD kit Pneumonia has a mortality rate of 12 to 14% despite antibiotic treatment and is one of the most common causes of death among infectious disease. In particular, the elderly has a higher mortality rate, and the prevalence of pneumonia and the resulting mortality rate are on the rise due to the rapid increase in the elderly population. It can help treat macrolide antimicrobial resistance by detecting the exact causative bacteria of pneumonia in respiratory samples of people with respiratory infections and revealing genetic mutations in mycoplasma pneumonia. • Highly...

 Open the catalog to page 9
WELLS BIO MDx Portfolio Brochure_Eng-10

COVID-19 RT-PCR kit careGENE™ COVID-19 RT-PCR kit is developed to use the real-time RT-PCR method using Taqman probe. RNA extracted from patient specimen is converted into the complementary DNA (cDNA) by reverse-transcription and target genes are amplified by polymerase chain reaction using primers specific to two site at viral genome in order to detect N gene and RdRP gene simultaneously. In this process, the fluorescence signal decomposed from the fluorescence probe is detected by real-time RT-PCR. • One Step Real-Time Reverse Transcription PCR Technology • Preventing contamination using the...

 Open the catalog to page 10
WELLS BIO MDx Portfolio Brochure_Eng-11

N-CoV RT-PCR kit careGENE™ N-CoV RT-PCR kit is an in vitro diagnostic medical device for qualitative detection of coronavirus disease (COVID-19) from RNA extracted from human Nasopharyngeal swab, Oropharyngeal swab and sputum using real-time RT-PCR (Reverse transcription-Polymerase Chain Reaction). • One Step Real-Time Reverse Transcription PCR Technology • Preventing contamination using the UDG (Uracil-DNA Glycosylase System) • Endogenous control included for sample extraction and amplification efficiency verification • Reaction time within 83 min (Improving laboratory efficiency) (E gene) •...

 Open the catalog to page 11
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.